Yang Qu hopes to lead the way in unlocking the full potential of cannabis—both commercially and medicinally—just as he did as one of Canada's foremost anti-cancer drug researchers.
A new analysis in CMAJ (Canadian Medical Association Journal) outlines the potential government cost of a national Canadian pharmacare program and sets out approaches to shifting the funding for drugs in Canada to realize billions in savings.